Novartis India

50
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
1,295.10
-8.75 (-0.67%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 16.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
2,173.00
-1,817.00
-83.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
2,173.00
-1,817.00
-83.62%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
21.00
-18.00
-85.71%
Raw Materials Consumed
199.00
1,376.00
-1,177.00
-85.54%
Power & Fuel Cost
0.00
148.00
-148.00
-100.00%
Employee Cost
18.00
85.00
-67.00
-78.82%
Operating Expenses
8.00
203.00
-195.00
-96.06%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
55.00
-45.00
-81.82%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
10.00
-1.00
-10.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
1,908.00
-1,644.00
-86.16%
Operating Profit (PBDIT) excl Other Income
91.00
265.00
-174.00
-65.66%
Other Income
41.00
13.00
28.00
215.38%
Operating Profit (PBDIT)
133.00
278.00
-145.00
-52.16%
Interest
0.00
32.00
-32.00
-100.00%
Profit before Depriciation and Tax
132.00
246.00
-114.00
-46.34%
Depreciation
2.00
47.00
-45.00
-95.74%
Profit Before Taxation & Exceptional Items
130.00
198.00
-68.00
-34.34%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
198.00
-68.00
-34.34%
Provision for Tax
29.00
41.00
-12.00
-29.27%
Profit After Tax
100.00
157.00
-57.00
-36.31%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
1,052.00
-324.00
-30.80%
Profit Available for appropriations
829.00
1,209.00
-380.00
-31.43%
Appropriations
829.00
1,209.00
-380.00
-31.43%
Equity Dividend (%)
500%
10%
490.00
Earnings Per Share
40.87
17.24
23.63
137.06%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024